Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced ...

A top-level international research team including researchers from the University of Eastern Finland has developed a new algorithm for the diagnostics of dementia. The algorithm is based on blood and ...

Please provide your email address to receive an email when new articles are posted on . AI algorithms to diagnose skin cancer had lower sensitivity and specificity when tested on a multimodal, ...

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory. Objectives: To understand real-world implementation of the updated CDC HIV ...

Up to 40% of rare diseases show facial alterations that enable researchers to identify some pathologies and they can even help them to establish an early diagnosis. Historically, the visual evaluation ...

A new diagnostic test can accurately distinguish osteoarthritis (OA) from inflammatory arthritis using two synovial fluid biomarkers, according to research published in the Journal of Orthopaedic ...

In a recent study, scientists employed machine-learning algorithms to classify fMRI data. Alzheimer's disease (AD) is a neurodegenerative disorder that affects a significant proportion of the older ...

As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry's first fully-transparent machine learning platform for clinical real-time PCR diagnostics – ...

Rare diseases can often be difficult to diagnose because their symptoms can overlap with a variety of conditions. One such disease is acute hepatic porphyria (AHP), a rare genetic disease with ...